Theo Holdings, LLC Patent applications |
Patent application number | Title | Published |
20140045787 | Hypertonic Dextran Solution and Methods of Treating and Preventing Recurrent Corneal Erosion - An ophthalmic solution is provided. The ophthalmic solution is hypertonic. The ophthalmic solution includes a polysaccharide having an average molecular weight of between about 40,000 grams per mole and about 150,000 grams per mole. A packaged ophthalmic solution for preventing the ophthalmic solution from being exposed to CO | 02-13-2014 |
20140045786 | Hypertonic Dextran Solution and Methods of Treating and Preventing Recurrent Corneal Erosion - An ophthalmic solution is provided. The ophthalmic solution is hypertonic. The ophthalmic solution includes a polysaccharide having an average molecular weight of between about 40,000 grams per mole and about 150,000 grams per mole. A packaged ophthalmic solution for preventing the ophthalmic solution from being exposed to CO | 02-13-2014 |